Actively Recruiting
A Study With Central Nervous System Metastatic EGFR Mutation Positive Non-small Cell Lung Cancer
Led by Hunan Province Tumor Hospital · Updated on 2024-09-20
100
Participants Needed
1
Research Sites
104 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a descriptive observational study, in which data are collected in an epidemiological fashion and prospective. This study does not intend to intervene the current medical practice of the recruited patients.
CONDITIONS
Official Title
A Study With Central Nervous System Metastatic EGFR Mutation Positive Non-small Cell Lung Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients must be 18 years or older
- Patients must provide fully informed consent before any study procedures
- Patients must have an EGFR 19Del or L858R mutation confirmed by histology or cytology
- Patients must have untreated advanced Non-Small Cell Lung Cancer (NSCLC)
- Patients must have at least one measurable lesion according to RECIST 1.1 criteria
You will not qualify if you...
- None
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hunan Cancer hospital
Changsha, Hunan, China
Actively Recruiting
Research Team
Y
Yongchang Zhang, MD
CONTACT
N
Nong Yang, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here